Debra is the UK and Ireland Business Development Manager for MaxCyte supporting customers and partners across both cell and gene therapy and bioprocessing fields. Debra received her PhD from Cardiff University studying the role of the cardiac ryanodine receptor in CPVT and sudden cardiac death. Since completing her PhD in 2009, Debra has worked at various companies including Miltenyi Biotec, GE Healthcare Lifesciences and Cytiva, before moving to MaxCyte, offering dedicated support and advice to their customer base. Please connect with her should a discussion be useful.